For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome

Hello. We're improving abcam.com and we'd welcome your feedback.

Hello. We're improving abcam.com and we'd welcome your feedback.

Infomation icon

We haven't added this to the BETA yet

New BETA website

New BETA website

Hello. We're improving abcam.com and we'd welcome your feedback.

Take a look at our BETA site and see what we’ve done so far.

Switch on our new BETA site

Now available

Search and browse selected products

  • A selection of primary antibodies

Purchase these through your usual distributor

In the coming months

  • Additional product types
  • Supporting content
  • Sign in to your account
  • Purchase online
United States
Your country/region is currently set to:

If incorrect, please enter your country/region into the box below, to view site information related to your country/region.

Call (888) 77-ABCAM (22226) or contact us
Need help? Contact us

  • My account
  • Sign out
Sign in or Register with us

Welcome

Sign in or

Don't have an account?

Register with us
My basket
Quick order
Abcam homepage

  • Research Products
    By product type
    Primary antibodies
    Secondary antibodies
    ELISA and Matched Antibody Pair Kits
    Cell and tissue imaging tools
    Cellular and biochemical assays
    By product type
    Proteins and Peptides
    Proteomics tools
    Agonists, activators, antagonists and inhibitors
    Cell lines and Lysates
    Multiplex Assays
    By research area
    Cancer
    Cardiovascular
    Cell Biology
    Epigenetics
    Metabolism
    Developmental Biology
    By research area
    Immunology
    Microbiology
    Neuroscience
    Signal Transduction
    Stem Cells
  • Customized Products & Partnerships
    Customized Products & Partnerships

    Customized products and commercial partnerships to accelerate your diagnostic and therapeutic programs.

    Customized products

    Partner with us

  • Support
    Support hub

    Access advice and support for any research roadblock

    View support hub

    Protocols

    Your experiments laid out step by step

    View protocols

  • Events
    • Conference calendar
    • Cancer
    • Cardiovascular
    • Epigenetics & Nuclear signaling
    • Immunology
    • Neuroscience
    • Stem cells
    • Tradeshows
    • Scientific webinars
    Keep up to date with the latest events

    Full event breakdown with abstracts, speakers, registration and more

    View global event calendar

  • Pathways
    Cell signalling pathways

    View all pathways

    View all interactive pathways

Quality recombinant SARS-CoV-2 proteins for research

Related

  • Cytokine storm in COVID-19 info and products
    • SARS_CoV-2 cell entry mechanism
      • Blood-based biomarkers for COVID-19
        • SimpleStep ELISA in COVID-19 webinar
          • Info and products for coronavirus research
            • Maximize research efficiency on the return to the lab
              • A new era for bioactive proteins
                • SARS-CoV-2 infection serology

                  Consistent supplies of quality recombinant SARS-CoV-2 proteins have been limited. Our own in-house manufacture of these fit-for-purpose recombinant proteins aims to remove these research barriers.


                  Recombinant SARS-CoV-2 proteins are essential reagents to support research into the biology of the virus and to act as controls when testing newly developed diagnostics and vaccines during trials. These proteins can be challenging and time-consuming to produce, especially under the new restricted working conditions. To help overcome the scarcity of these essential reagents in the scientific community and increase the speed of research for COVID-19, Abcam is manufacturing a range of fit-for-purpose, recombinant SARS-CoV-2 proteins.  

                  The first protein we have launched onto our catalog is the recombinant human SARS-CoV-2 nucleocapsid protein. We are continuing to develop our COVID-19 protein pipeline, with highly relevant targets, such as the SARS-CoV-2 spike protein coming soon. These are available for immediate purchase from the catalog or as custom larger sizes to support your research.

                  Function and therapeutic targeting of the SARS-CoV-2 nucleocapsid protein

                  The nucleocapsid protein is a structural protein that binds to the SARS-CoV-2 RNA genome, enclosing the nucleic acid within this capsid. This protein plays many roles in the viral life cycle: interacting with the viral membrane protein during viral assembly, assisting in RNA synthesis and folding, playing a role in virus budding, and affecting host cell responses, including cell cycle and translation 1.

                  The nucleocapsid protein of SARS-CoV-2 is a key drug target and target antigen for vaccine development 2,3. Showing higher conservation and stability levels than the SARS-CoV-2 spike protein, the nucleocapsid protein suffers fewer mutations over time 4-7. This could be beneficial in increasing the longevity of any vaccine developed using this target antigen.

                  Our new recombinant proteins for COVID-19 research can be used in in vitro assays to understand how the SARS-CoV-2 virus functions to developing and testing diagnostics and therapeutics.

                  Consistent production of quality recombinant proteins

                  As soon as the SARS-CoV-2 sequence was published in early 2020, recombinant proteins have been being produced to support scientists studying COVID-19. However, the supply of these recombinant proteins has been limited within the community, hindering valuable research 8,9. Understanding the need for fit-for-purpose protein products, we have pivoted our protein engineering and production facilities to manufacture key targets for COVID-19, and support scientists in combatting this disease.

                  Manufacturing these key recombinant protein targets in-house at Abcam, allows us to ensure the protein quality and batch-to-batch consistency is maintained across the product lifecycle, enabling reliable and reproducible research.

                  When producing recombinant proteins for research, the end use of the protein is an important consideration. For example, endotoxin levels in the protein reagent may be vital in sensitive cell assays, whereas for ELISA this isn’t a concern. We offer different protein grades so that researchers can choose the optimal protein purity and activity levels for their requirements.

                  View our latest premium bioactive grade proteins with optimal bioactivity, ultra-low endotoxin levels and ultra-high purity.

                  Get the SARS-CoV-2 N protein

                  Abcam’s products are intended for research use only, not for use in diagnostic, therapeutic or any other purposes.


                  References

                  1. Surjit M and Lal SK. The Nucleocapsid Protein of the SARS Coronavirus: Structure, Function and Therapeutic Potential. Mol Biol of SARS coronavirus. 129–151 (2009)
                  2. Dutta NK et al. The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development. J Virol.  94(13) e00647-20 (2020)  
                  3. Kang S et al. Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites. Acta Pharm Sin B doi: 10.1016/j.apsb.2020.04.009. Online ahead of print. (2020)
                  4. Drosten C et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Eng J Med 348(20):1967-76. (2020)
                  5. Grifoni A et al. A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2. Cell Host Microbe 27(4): 671–680.e2 (2020)
                  6. Marra MA et al. The Genome sequence of the SARS-associated coronavirus. Science. 300(5624):1399-404. (2003)
                  7. Zhu Y et al. Isolation of virus from a SARS patient and genome-wide analysis of genetic mutations related to pathogenesis and epidemiology from 47 SARS-CoV isolates. Virus Genes 30(1):93-102 (2005)
                  8. Brianna Abbot, “Shortage of test components forces labs to beg, borrow and improvise,” Wall Street Journal, April 5, 2020, wsj.com
                  9. Ana Mano, “As Brazil’s COVID-19 testing lags, available labs go unused,” Reuters, April 15, 2020, uk.reuters.com.





                  Get resources and offers direct to your inbox Sign up
                  A-Z by research area
                  • Cancer
                  • Cardiovascular
                  • Cell biology
                  • Developmental biology
                  • Epigenetics & Nuclear signaling
                  • Immunology
                  • Metabolism
                  • Microbiology
                  • Neuroscience
                  • Signal transduction
                  • Stem cells
                  A-Z by product type
                  • Primary antibodies
                  • Secondary antibodies
                  • Biochemicals
                  • Isotype controls
                  • Flow cytometry multi-color selector
                  • Kits
                  • Loading controls
                  • Lysates
                  • Peptides
                  • Proteins
                  • Slides
                  • Tags and cell markers
                  • Tools & Reagents
                  Help & support
                  • Support
                  • Make an Inquiry
                  • Protocols & troubleshooting
                  • Placing an order
                  • RabMAb products
                  • Biochemical product FAQs
                  • Training
                  • Browse by Target
                  Company
                  • Corporate site
                  • Investor relations
                  • Company news
                  • Careers
                  • About us
                  • Blog
                  Events
                  • Tradeshows
                  • Conferences
                  International websites
                  • abcam.cn
                  • abcam.co.jp

                  Join with us

                  • LinkedIn
                  • facebook
                  • Twitter
                  • YouTube
                  • Terms of sale
                  • Website terms of use
                  • Cookie policy
                  • Privacy policy
                  • Legal
                  • Modern slavery statement
                  © 1998-2023 Abcam plc. All rights reserved.